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Abstract  1.  Introduction 
The  X-ray  structure  of  the  36kDa  soluble  lytic 
transglycosylase from  Escherichia  coli has  been  deter- 
mined  starting  with  the  multiple  isomorphous  replace- 
ment method with  inclusion of anomalous scattering at 
2.7 A  resolution.  Subsequently, before any model build- 
ing  was  carried  out,  phases  were  extended  to  1.7 A, 
resolution  with  the  weighted  automated  refinement 
procedure  wARI~, which  gave  a  dramatic  improvement 
in  the  phases.  The  electron-density  maps  from  wARP 
were of outstanding quality for both the main chain and 
the  side  chains  of the  protein,  which  allowed  the  time 
spent on the tracing,  interpretation and building of the 
X-ray structure to be substantially shortened. The structure 
of the soluble lyric transglycosylase was refined at 1.7 A, 
resolution  with  X-PLOR  to  a  final  crystallographic  R 
factor  of  18.9%.  Analysis  of  the  wARP  procedure 
revealed  that  the  use  of  the  maximum-likelihood 
refinement  in  wARP  gave  much  better  phases  than 
least-squares  refinement,  provided  that  the  ratio  of 
reflections to protein atom parameters was approximately 
1.8 or higher. Furthermore, setting aside 5% of the data 
for an  Rfrce test  set  had  a  negative effect  on  the  phase 
improvement. The mean  Wwmu,, a weight determined at 
the end of the wARP procedure and based on the variance 
of structure  factors from six  individually refined wARP 
models,  proved  to  be  a  better  indicator  than  the  Rf~ce 
factor  to judge  different  phase  improvement protocols. 
The elongated S1t35 structure has three domains named 
the  alpha,  beta  and  core  domains.  The  alpha  domain 
contains mainly a-helices, while the beta domain consists 
of a five-stranded antiparallel r-sheet flanked by a short 
a-helix. Sandwiched between the alpha and beta domains 
is the core domain, which bears some resemblance to the 
fold of the catalytic domain of the previously elucidated 
70 kDa soluble lytic transglycosylase from E.  coli.  The 
putative active site is at the bottom of a large deep groove 
in the core domain. 
t"  Present  address:  EMBL,  c/o  ILL,  BP  156,  F-38042  Grenoble 
CEDEX,  France. 
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Almost  all  bacteria  possess  a  cell  wall  consisting  of 
peptidoglycan,  a  biopolymer  built  up  from  linear 
polysaccharide  strands  of  alternating  N-acetylglucos- 
amine (GIcNAc) and N-acetylmuramic acid (MurNAc) 
residues,  which  are  cross-linked  by  short  oligopeptide 
chains  (reviewed  by Dijkstra  &  Keck,  1996).  The  cell 
wall  gives  the  organism  its  shape  and  protects  it  from 
lysis. Maintaining the integrity of the cell wall is of vital 
importance  to  the  bacterium,  and  compounds  that 
interfere  with  the  correct  action  of  peptidoglycan 
metabolizing enzymes are oiten lethal.  Prime examples 
of  such  antibacterial  compounds  are  penicillins  and 
related fl-lactams, which inhibit the enzymes involved in 
the  cross-linking of peptidoglycan.  However,  the wide- 
spread use of such antibiotics has led to the emergence of 
resistance  and  novel  compounds  to  inhibit  bacterial 
growth and multiplication are of vital importance (Gold 
&  Moellering,  1996). 
Our research is focused on enzymes that are important 
for  the  metabolism  of  the  glycan  strands,  with  the 
objective  to  characterize  their  role  in  peptidoglycan 
metabolism and to make them amenable for the design of 
novel  antibiotics.  Previously,  we  described  the  X-ray 
structures  of the  70 kDa  soluble  lytic  transglycosylase 
(Slt70) from Escherichia  coli (Yhunnissen et al.,  1994) 
and its complex with bulgecin (Thunnissen, Rozeboom, 
Kalk  &  Dijkstra,  1995),  a  naturally  occurring  Sit70 
inhibitor  produced  by  Pseudomonas  acidophila  and 
Pseudomonas  mesoacidophila.  Here  we  describe  the 
X-ray  structure  elucidation  of a  36kDa  soluble  lytic 
transglycosylase  from  E.  coli,  which  has  been  named 
Slt35  (Engel,  Smink,  van  Wijngaarden  &  Keck,  1992) 
and which has no significant sequence similarity to Slt70. 
Both  S1t35 and  Slt70 cleave the fl(1,4)-glycosidic bond 
between a  MurNAc and GlcNAc  residue of peptidogly- 
can.  The  cleavage  is  subsequently  followed  by  an 
intramolecular transglycosylation reaction,  in which the 
C6-hydroxyl group of MurNAc attacks the C1  atom of 
the  same  residue  forming  an  1,6-anhydromuropeptide 
product  (H61tje,  Mirelman,  Sharon  &  Schwarz,  1975; 
Dijkstra, Hermann & Keck,  1995). 
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The  X-ray  structure  of Slt35  was  solved  by multiple 
isomorphous  replacement  including  anomalous  differ- 
ences  (MIRAS)  with  subsequent  application  of  the 
weighted automated refinement procedure  wARP (Perra- 
kis,  Sixma,  Wilson  &  Lamzin,  1997).  The  recently 
developed  wARP  procedure  makes  use  of  models 
consisting  of free  atoms  placed  in  significant  electron 
density  in  an  initial  map.  Several  so-called  pseudo 
protein  models  are  generated  and  subjected  to  unrest- 
rained  least-squares  or  maximum-likelihood  refinement 
and  iterative  model  updating  with  the  automated 
refinement  procedure,  ARP  (Lamzin  &  Wilson,  1993). 
To minimize noise and to enhance the overall accuracy of 
the  phases,  the  calculated  structure  factors  from  the 
refined pseudo protein models are subsequently averaged 
to obtain the final phase set.  In the case of Slt35, wARP 
proved to be very effective in improvement and extension 
of MIRAS phases to high resolution, prior to any model 
building.  The  wARP  electron-density  map  was  of 
outstanding  quality,  considerably  facilitating  map  inter- 
pretation  and  model  building.  In  this  article  we  give 
details of the structure determination of Slt35 and discuss 
the influence  of various parameters  on the effectiveness 
of wARP. 
2.  Materials  and methods 
2.1.  Crystallization 
The  Slt35  protein,  encoded  by  the  mltB  gene,  was 
cloned, overexpressed and purified as previously reported 
(Dijkstra et al.,  1995).  As Slt35 is a lipoprotein with the 
lipid anchor and active domain separated by a proteolysis 
susceptible spacer, a 36 kDa soluble fragment lacking the 
membrane anchor and spacer, was constructed starting at 
residue  41  with  two  additional  residues  (Met39  and 
Val40)  at  the  N  terminus.  In  the  presence  of  150 mM 
NaC1,  1%  isopropanol,  1%  polyethylene  glycol  20 000 
(PEG 20K)  and  20 mM Hepes  (pH  7.5),  this  protein  is 
stable  and  can  be  stored  at  253 K.  For  crystallization 
experiments, the protein was first diluted to a concentra- 
tion  of  7.0 mg ml-land  subsequently  dialysed  for  6 h 
against a  solution  containing  10 mM Tris-HC1, pH  7.2, 
1% isopropanol and 1 mM phenylmethylsulfonyl fluoride 
(PMSF). 
Rod-shaped  crystals  with  typical  sizes  of 
0.25  x  0.25  x  1.0 mm were grown at 295 K  in  1 d to  1 
week by equilibrating  a  hanging drop,  that consisted  of 
3 ~1  of dialysed  protein  solution  and  3 ~1  of reservoir 
solution,  against  1 ml  of reservoir  solution  of  100 mM 
Bicine-NaOH  buffer,  pH  7.8-8.5  and  0-6%  PEG 20K. 
After  growth,  crystals  were  stored  in  a  stabilizing 
solution  containing  100 mM  Bicine-NaOH  (pH  8.0- 
8.5),  1%  isopropanol,  and  5-10%  PEG20K.  Slt35 
crystallizes  in  the  primitive  orthorhombic  space  group 
P212121  with  cell  dimensions  a  =  58.3,  b =  67.9  and 
c =  98.9 ~. With one molecule per asymmetric unit, the 
value of the Matthews coefficient,  V,, (Matthews,  1968), 
is 2.72/~3 Da-~.  Assuming a partial specific volume for 
globular proteins of 0.74 cm  3 g-~, the solvent content of 
the crystals is estimated to be about 55%. 
2.2.  Data collection  and processing 
For diffraction experiments,  crystals were flash frozen 
in a stream of evaporating nitrogen of 120 K after being 
soaked  for  1 min  in a  cryo-protectant consisting  of 25- 
35%  glycerol added  to  the  stabilizing  solution.  Data to 
1.7,~  resolution  were  collected  from  a  native  Slt35 
crystal (stored at pH 8.5) at a wavelength  of 0.920 A, at 
the  A1  station  at  CHESS  (Cornell  High  Energy 
Synchrotron  Source)  in  Ithaca  (USA),  using  a  CCD 
camera as detector. A second data set to 2.0 ,~ resolution 
was  collected  from  the  same  crystal  with  the  beam 
attenuated  by  aluminium  foil  to  measure  strong  low- 
angle  reflections  saturated  in  the  first  set.  Data  were 
processed  with DENZO and SCALEPACK (Otwinowski, 
1993).  Intensities  were  converted  to  structure-factor 
amplitudes with programs from the Groningen BIOMOL 
software  package  (Groningen  protein  crystallography 
group).  Fig.  1 shows the completeness  and the Rmerg c  of 
the diffraction data as a function of resolution. 
In  the  course  of an  extensive  heavy-atom  derivative 
search,  diffraction  data  were  collected  on  a  FAST area 
detector  (Enraf-Nonius,  Delft,  The  Netherlands)  using 
Cu Ko~ radiation from an Enraf-Nonius  FR571  rotating- 
anode  generator  with  a  graphite  monochromator.  Data 
reduction was performed with MADNES (Messerschmidt 
&  Pflugrath,  1987),  XDS (Kabsch,  1988)  and  BIOMOL 
programs.  Data  for  a  mercury  derivative  (Hg-IlI)  were 
measured at beamline BW7A of the EMBL Outstation at 
DESY, Hamburg (Germany), at a wavelength of 0.970/~, 
with  a  MAR  Research  (Hamburg)  imaging  plate  as 
detector. These data were processed with DENZO.  Data- 
collection statistics are summarized  in Table  1. 
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Fig. 1. Completeness and Rmerg  e of the data as a function of resolution. 
Filled squares indicate the  completeness for  all  reflections with 
I > 0, open squares for those with I > 3a(1). The filled triangles 
show the merging R factor (Rmerg  e =  Z  11 -  (1)l/E l) for symme- 
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Table  1.  Data-collection  statistics for Slt35 data sets 
Native  Os-I?  Pb-lt  Hg-II  Hg-IIi"  Hg-IIIt 
X-ray source  CHESS  Rotating  Rotating  Rotating  Rotating  EMBL/DESY 
A1  station  anode  anode  anode  anode  BW7A 
Wavelength (A)  0.920  1.542  1.542  1.542  1.542  0.970 
Detector  CCD  FAST  FAST  FAST  FAST  MAR 
Soaking 
Concentration  (raM)  3.0  12  3.0  2.0  3.0 
Time  --  4 d  24 h  6 d  8 d  2 h 
Space group P212121 
Cell dimensions (A) 
a  58.3  58.3  58.3  58.3  58.4  58.3 
b  67.9  67.8  67.5  67.6  67.9  67.7 
c  98.9  98.1  98.9  98.7  98.8  98.5 
Resolution  (A)  29.6-1.70  33.9-3.00  33.8-3.44  33.8-2.69  33.9-2.70  17.5-2.02 
No. of reflections 
Total  206582  23113  21880  20201  23732  92150 
Unique  41653  7954  5096  9063  9339  24767 
Overall 
Completeness  (%)  94.4  96.6  91.8  80.0  82.6  94.0 
(1~or(l))  24.4  22.5  20.4  27.2  26.6  30.4 
Rm~rge  ~ (%)  5.0  5.6  7.4  3.7  4.2  3.8 
R,~t§ (%)  --  9.3  6.0  6.2  7.1  6.9 
1 Os-I = K2OsO4-2H20; Pb-I = trimethyllead  acetate; Hg-I = para-chloromercuryphenylsulfonic acid; Hg-II = para-chloromercury-benzoic acid 
and Hg-IIl = 2-chloromercury-4-nitrophenol.  :~ gmerge =  Z  II -  (I)I/Z I.  § gnat =  Zhk/I(Fp  -- Fptt)J/Zhkl 0.5(Fp "t- FpH). 
Table 2. Phasing statistics for Slt35 
Heavy-atom compound  Os-I  Pb-I  Hg-I  Hg-lI  Hg-llI 
High-resolution  limit (A)  3.03  3.44  2.70  2.70  2.70 
Number of sites  4  2  7  5  6 
Phasing powert 
Iso  1.29  0.97  1.56  1.39  0.88 
Ano  0.51  0.37  0.69  0.69  1.20 
Rcunis  +  0.578  0.657  0.552  0.608  0.657 
Rr,~u~ 
Is~  0.121  0.083  0.074  0.090  0.097 
Ano¶  0.125  0.083  0.075  0.089  0.099 
Figure of merit (overall)  0.604 (for 10418 reflections from 24.0 
to 2.70 A resolution) 
~" Phasing  power  =  ~-]hk,  IFn(calc)l/~'~h~,  IIFpHI- IFp.(calc)ll. 
++ Rcullis  =  Shkt llFpn + FpI  -  FH(calc)J/ ~hu lFp. +  FpI. 
§ RK,..t(iso)  =  ~-~.hk,/IFp.I  -IFpH(Calc)ll/~h*t  IFeHI"  ¶  RK  .... (ano) 
=  )--~.hktl[Fprr --Fpn.(calc)l  +  IFpn- -Fpa_(calc)ll/y~.hkt([FpH. I 
+  IFpH-I). 
2.3. Multiple isomorphous  replacement  including anom- 
alous scattering 
The  structure  of  Slt35  was  solved  by  multiple 
isomorphous  replacement  including  anomalous  scatter- 
ing  differences  using  five  heavy-atom  derivatives: 
K2OsO4.2H20  (data  set  Os-I),  trimethyl-lead  acetate 
(Pb-I),  parachloromercury-phenylsulfonic  acid  (Hg-I), 
parachloromercury-benzoic  acid  (Hg-II)  and  2-chloro- 
mercury-4-nitrophenol (Hg-III). The derivative data were 
scaled  to  the  native  data  set  with  programs  from  the 
PHASES package  (Furey &  Swaminathan,  1998).  The 
first  two heavy-atom sites  for derivatives Os-I,  Hg-I and 
Hg-II  were determined from  difference  Patterson  maps. 
All  other  heavy-atom  positions  were  located  in  cross- 
difference  Fourier  maps  with  phases  calculated  from 
Electron density map covering 
one asymmetric unit 
(  ,,=0 a=,  0°ns,   ) 
to generate pseudo protein models 
Selection of three pseudo protein models ) 
Least-squares or maximum likelihood 
refinement combined with ARP 
Tidying up the refined models and generation') 
of three new pseudo protein models  .,) 
(  Least-squares or maximum likelihood  ~ 
refinement combined with ARP 
Vector-averaging of 
structure factor amplitudes and phases 
wARP electron  density  map ] 
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other derivatives.  Anomalous scattering information was 
used to establish the correct hand of the structure and to 
improve  phases.  Heavy-atom  parameters  were  refined 
with PHASES,  keeping  individual  atomic  displacement 
parameters  constant  at  20.0 A2.  The  MIRAS  map  was 
solvent flattened using PHASES assuming  50%  solvent 
content.  Heavy-atom  parameters,  now  including  the 
atomic  displacement parameters,  were  further improved 
by refinement against the phases  resulting from solvent 
flattening. Although the data for Hg-III nominally extend 
to 2.0/k resolution,  the phasing power was low beyond 
2.7 A,  and,  therefore,  this  derivative  was  only used  to 
2.7 A resolution (Table 2). The final figure of merit after 
completion of the heavy-atom-parameter refinement was 
0.60 at 2.7 A resolution. 
2.4. Phase extension  and improvement using wARP 
The recently developed wARP procedure  (Perrakis  et 
al., 1997) was used to extend and improve the phases for 
Slt35. The entire method can be divided in seven major 
steps as can be seen in the flow diagram (Fig.  2). In the 
following we discuss the use of these steps in more detail. 
2.4.1. Input electron-density map. To apply the wARP 
procedure for phase extension and improvement, an input 
electron-density  map  with  phases  extending  to  2.5/k 
resolution  is  recommended  (Perrakis  et  al.,  1997). 
Therefore,  MIRAS  phases  to  2.7 A  resolution  were 
extended to  2.5/k  resolution  using  the  program  DM 
(Cowtan  &  Main,  1993)  with  solvent  flattening  and 
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Fig.  3.  wARP  procedure of placing 
atoms in electron density. (a) 2.5 A 
resolution  electron-density  map 
after  phase  extension  with  DM 
contoured  at  1.0a  and  covering 
one  asymmetric unit  of the  cell. 
For clarity, the map is not shown in 
(b)-(e).  (b) A  polyalanine a-helix 
of 20 residues placed in the protein 
part of the electron density. (c) 600 
atoms  placed  near  the  a-helical 
seed.  (d)  Atoms  placed  in  2.0a 
density  after  removal  of  the  or- 
helical  seed.  (e)  Pseudo  protein 
model containing 8187 atoms after 
finishing the placement of atoms in 
electron density. (f) Pseudo pro- 
rein  model  consisting  of  2750 
atoms after truncation. See §2 for 
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subsequently used to calculate a figure-of-merit weighted 
F o  electron-density  map  covering  the  asymmetric  unit 
with a very fine grid spacing of 0.25 A. 
2.4.2.  Placing atoms inside density to generate pseudo 
protein models, wARP makes use of models consisting of 
free atoms placed in significant electron density. As these 
atoms are not bonded to each other we call these sets of 
atoms pseudo protein models. The generation of pseudo 
protein  models  requires  a  seed  of approximately  100 
atoms  placed  somewhere  in  the  protein  region  of the 
input electron-density map.  For that purpose,  we took a 
polyalanine helix of 20 residues which was placed in an 
arbitrary  orientation  inside  density  representing  the 
protein  molecule.  The  building  of the  pseudo  protein 
models  was  initiated  by  placing  O  atoms  with  the 
program  ARP (Lamzin  &  Wilson,  1993)  at  grid points 
with a density of at least 2.00" above the mean, and within 
5.0 A  from an  atom  in  the polyalanine  helix.  After the 
first cycle,  in  which  600  atoms  were  placed,  the  initial 
polyalanine  helix  was  removed  and  the  pseudo  protein 
model was slowly expanded in the next cycles by adding 
gradually  atoms  in  significant  electron  density  at 
distances  1.1  to  1.8 A  from  existing  atoms.  When  no 
more atoms could be found that obeyed these conditions, 
the density threshold was lowered in steps of 0.10" from 
2.0 to 0.90" to place more atoms in weaker sections of the 
electron  density,  Occasionally,  breaks  in  the  electron 
density are present in the protein main chain or between a 
side  chain  and  the  main  chain.  Therefore,  by  placing 
atoms  in  weaker  density,  good  density regions  become 
connected  to each  other.  Fig.  3  illustrates the procedure 
of placing atoms  inside electron density.  The intermedi- 
ate sets of atoms generated at the various levels were kept 
for the next step in the wARP procedure. 
2.4.3. Selection of three pseudo protein models. In the 
Slt35  crystal,  there  is  one  protein  molecule  per  asym- 
metric unit containing approximately 2 500 atoms. In the 
wARP  procedure,  three  starting  models  were  selected 
from  the  atom  sets  generated  in  the  previous  step  that 
contained  approximately  1.5,  2.0  and  3.0  times  the 
expected number of protein atoms in the asymmetric unit 
of the cell. Subsequently, the number of atoms in each of 
these  models  was  reduced  to  110%  of  the  expected 
number  of atoms  (2 750)  to  allow  for  strongly  bound 
solvent  molecules,  by  rejecting  atoms  in  the  weakest 
density.  The  three  atom  sets  are  called  pseudo  protein 
models  1,  2  and  3.  The  individual  displacement 
parameters for all atoms were set to the B factor derived 
from a Wilson plot (Wilson,  1949),  18.4 A 2. 
2.4.4.  Refinement  of the first  three  pseudo  protein 
models. The three pseudo protein models were refined in 
a  cyclic  procedure  of  unrestrained  reciprocal-space 
refinement  either with SFALL (least-squares  refinement; 
Agarwal,  1978;  Collaborative  Computational  Project, 
Number  4,  1994)  or  with  REFMAC  (maximum-like- 
lihood refinement;  Murshudov,  Vagin &  Dodson,  1997), 
followed  by  real-space  refinement  and  iterative  model 
Table 3. Refinement statistics of Slt35 
Resolution range (A)  20.0-1.70 
Number of reflections 
Total  41498 
Work set  37284 
Test set  4214 
Final R  factor (%)]  18.9 
Rwork factor (%):[:  18.7 
R~e  e factor (%)§  22.1 
R.m.s.d.  bond lengths (A)¶  0.009 
R.m.s.d.  bond angles (°)¶  1.4 
Non-H protein atoms  2456 
Residues  42-97  and  109-361 
Alternate  side chains  5 
Solvent molecules  312 
Average B  factor (A  2) 
All atoms  23.4 
i" Final  R  factor  =  y~hkt[IFo(hkl, all)[ -- [F,:(hkt, all)l]/ 
Y~hkt IFo(hkl, all)[.  ~: Rwork  factor  =  ~-]hkt[IF,,(hkl, work set)l- 
IFc(hkl, work set)l]/~hkt IFo(hkt, work set)l.  § Rfr~  factor  = 
~-~hkt[IFo(hkl, test set)l  -  IFc(hkl,  test set)l]/~hkl IFo(hkl, test set)l. 
¶  With respect to the  set of Engh & Huber parameters (Engh & 
Huber, 1991). 
updating  by ARP. Both  atomic  positional  and  displace- 
ment  parameters  were  refined.  Depending  on  the  high- 
resolution  limit  (Res)  and  the  number  of atoms  (N),  a 
maximum  of  (N x  0.08/Res 3)  atoms  were  located  in 
F o -F c  difference  density  above  the  3.5a  level  and 
added  to  the  model  in  each  cycle.  Likewise,  the  same 
number  of atoms  was  allowed  to  be  rejected  from  the 
model for one of the following reasons. (1) If the value of 
the 2mF  o -  DF  c electron density at the atomic centre was 
less than  1.5o" above the mean or (2) if any pair of atoms 
was  closer  than  0.6/k  to  each  other,  one  atom  was 
rejected and the other was assigned to the mean position 
of the two atoms.  In total, 20 cycles of refinement with 
SFALL or REFMAC and ARP were performed for each of 
these  three  starting  models.  The  progress  of  the 
refinement was followed with an Rfree factor using a test 
set  containing  5%  of  randomly  selected  observations 
(Briinger,  1992a).  For  reasons  of comparison,  a  low- 
resolution  cutoff of 8.0 A  was  chosen  for  both  least- 
squares  and maximum-likelihood  refinement as no bulk 
solvent  correction  could  be  applied  within  SFALL. 
Several different high-resolution limits were taken to test 
the convergence  of wARP (see §3). 
2.4.5.  Tidying up the refined models and generation of 
three  new  pseudo  protein  models.  The  three  refined 
pseudo  protein  models  were  slightly  changed  in  two 
steps.  First,  atoms  with  an  atomic  displacement  para- 
meter  larger  than  two  times  the  Wilson  B  factor  were 
discarded.  After that, the displacement parameters of all 
remaining atoms were reset to the B factor derived from 
the  Wilson  plot.  To  create  three  new  different  atomic 
models, a random positional shift of 0.5 A was applied to VAN ASSELT, PERRAKIS, KALK, LAMZIN AND DIJKSTRA  63 
Table 4.  Location of the heavy-atom sites in the Slt35 structure 
Derivative  Site  x  y  z  B  Occupancy  Protein ligands/remarks 
Os-I  1  0.72  0.10  0.81  36  1.00  Tyr234,  His263 
2  0.60  0.08  0.82  37  0.70  His340 
3  0.52  0.07  0.83  52  0.37  His340 
4  0.57  0.06  0.79  53  0.37  His340 
Pb-I  1  0.70  0.10  0.81  14  1.00  His263 
2  0.23  0.08  0.05  18  0.94  Tyr223 
Hg-I  1  0.35  0.24  1.00  19  1.00  Asp208,  Asn245 
2  0.94  0.22  1.00  18  0.96  Asp205, Glu206, His243 
3  0.70  0.10  0.81  20  0.23  Tyr234,  His263 
4  0.55  0.09  0.82  18  0.26  His340 
5  0.25  0.21  0.97  29  0.19  Probably sulfonic acid 
moiety of the Hg-complex 
in site  1 
6  0.42  0.25  0.01  14  0.16  Glu206, His243;  probably 
sulfonic acid moiety of the 
Hg-complex in site 2 
7  0.03  0.18  0.01  29  0.21  Val168, Glyl70, Lysl71, 
Gln207 of symmetry- 
related molecule. 
Hg-I!  1  0.94  0.22  1.00  19  1.00  Asp205, Giu206, His243 
2  0.35  0.24  0.99  19  0.92  Asp208,  Asn245 
3  0.55  0.09  0.82  21  0.62  His340 
4  0.70  0.11  0.81  22  0.37  Tyr234, Tyr259,  His263, 
Arg337 
5  0.62  0.10  0.81  23  0.28  His340,  Arg337 
Hg-llI  1  0.72  0.10  0.81  27  1.00  Tyr234, Tyr259, His263 
2  0.61  0.09  0.82  32  0.51  His340 
3  0.53  0.09  0.81  33  0.48  His340 
4  0.86  0.21  0.99  28  0.51  Glu206 
5  0.94  0.21  0.99  34  0.26  Asp208,  Iie244 
6  0.35  0.24  1.00  22  0.16  Glu206, His243 
all  atom  coordinates  of the  modified  models  using  the 
MOLEMAN program  (Kleywegt,  1995).  The application 
of random shifts and resetting of B factors, together with 
the removal  of atoms  in weak density gives a  consider- 
able  improvement  of  the  refinement  at  the  cost  of 
negligible  computing  time  (see  e.g.  Table  5d  and  5e). 
Apparently,  shaking  the  models  is  very  effective  in 
escaping  local refinement minima.  The newly generated 
atom sets were called pseudo protein models 4, 5 and 6, 
respectively. 
2.4.6.  Refinement  of all  six pseudo  protein  models. 
Each of the six pseudo protein models was subsequently 
refined with SFALL or REFMAC and updated with ARP 
in 20 cycles, as described  in §2.4.4.  At the end of these 
refinement  cycles,  atoms  located  in  electron  density 
below  2.0o-  in  a  2mF  o -DF,.  map  were  removed. 
Subsequently,  a  random  shift  of 0.5 A  was  applied  to 
all  remaining  atoms  in  the  six  models  and  the  atomic 
displacement parameters were truncated to a minimum of 
half the Wilson B factor and to a maximum of the value 
of  the  Wilson  B  factor.  The  modified  models  were 
subsequently refined in 20 additional  cycles. 
2.4.7.  Vector-averaging of structure factors. Structure- 
factor amplitudes and phases were calculated with SFALL 
for  each  of the  six  refined  models,  and  scaled  to  the 
observed  amplitudes  with  the  program  RSTATS (Colla- 
borative Computational Project, Number 4,  1994).  These 
calculated  structure  factors  were  vector-averaged  using 
the  program  REFLAVER  (Perrakis  et  al.,  1997)  to 
minimize  noise  and  to  enhance  the  overall  accuracy of 
the phases. To each structure factor a weight,  WwARP,  was 
assigned  based  on  the variance  of the  two-dimensional 
distribution of the individual structure factors around the 
average. The value of WwA~ is 1.0, if the structure factors 
from  all  six  models  are  the  same.  Large  differences 
between  structure  factors  will  lead  to  a  smaller  WwA  ~ 
value  with  zero  as  a  minimum.  With  the  final  vector- 
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Fig. 4. Mean phase differences with the phases calculated from the final 
refined S1t35 structure as a function of resolution with (-) MIRAS 
phases  to 2.7 A  resolution, (- -  -)  DM-modified phases  to 2.5 A 
resolution, (  .....  ) vector-averaged phases to 2.0 A resolution using 
maximum-likelihood refinement in  wARP  (used to build the  Slt35 
structure),  and (  .....  ) vector-averaged  phases to  1.7 A resolution 
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averaged structure-factor  amplitudes, phases and  WwA  ~ 
weights, F o and 2F  o -  F~ maps were computed. 
2.5. Model building and refinement 
Model  building  was  performed  with  the  interactive 
graphics program  O  (Jones, Zou,  Cowan &  Kjeldgaard, 
1991)  on  Silicon Graphics workstations.  The  quality of 
the wARP map allowed to take complete advantage of the 
model-building procedure included in the O package and 
especially  the  real-space  refinement  capabilities.  The 
model was  refined  with  the  program  X-PLOR  version 
3.843 (Bfiinger, 1992b) starting with residues 51-99 and 
109-360.  All atomic displacement parameters were set to 





Fig.  5.  F  o  electron-density maps 
contoured at 1.Oa at various stages 
of the structure determination  with 
the  final refined Slt35 model 
superimposed. Maps were calcu- 
lated with (a) MIRAS phases and 
FOM weights to 2.7 A resolution, 
(b) DM phases and FOM weights 
to  2.5A  resolution, (c)  vector- 
averaged  phases  and  WwARp 
weights  to  2.3A  using least- 
squares refinement in  wARI~. VAN ASSELT, PERRAKIS, KALK, LAMZIN AND DIJKSTRA  65 
reflections were  set  aside  (Brfinger,  1992a).  After  two 
cycles  of  refinement  including  simulated  annealing 
(3000-300 K), Powell energy minimization, overall and 
individual B-factor refinement and model rebuilding, the 
crystallographic Rwork and Rfree factors were respectively 
28.3  and  31.4%  for  data  between  8.0  and  1.7A 
resolution  and  with  residues  48-99  and  109-361 
included in the model. 
In  six  subsequent  refinement  and  model-rebuilding 
cycles,  the  low-resolution  limit for  the  diffraction data 
was extended to 20.0 A and a bulk solvent correction was 
applied.  A  part  of  the  N  terminus  (residues  42-47) 
showed up in a  an-weighted 2F o  -F  c  omit map (Read, 
1986; Bhat,  1988; Vellieux &  Dijkstra,  1997) and these 
residues were  added to  the model.  Residues 98  and 99 
had poor  electron  density and were removed.  The final 
(a9 
(e) 
Fig.  5.  (cont.)  (d)  Vector-averaged 
phases and Ww~  ~  weights  to 2.0/~ 
resolution using maximum-likeli- 
hood refinement  in wARP (used to 
build  the  S1t35 structure), (e) 
vector-averaged  phases  and 
Wwa  ~  weights to 1.7 A resolution 
using maximum-likelihood  refine- 
ment  in  wARP  and  (f)  a a- 
weighted  2F  o -F  c  map  using 
phases of the  final Slt35 model. 
The  map  correlation coefficients 
are, respectively,  (a) 60.2, (b) 74.3, 
(c) 78.2, (d) 80.8 and (e) 94.5%, 
with respect to a  electron-density 
map calculated with phases from 
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protein  model  contains  residues  42-97  and  109-361. 
Alternate  side-chain  conformations  were  observed  and 
built for Asp74, Asp139,  Trp145,  Glu153  and Arg204. 
Occupancies for double conformations were refined with 
the total occupancy  of each  pair constrained  to  1.0  in 
X-PLOR using a locally written script (E. van Asselt, 
unpublished  work).  In  addition,  312  solvent  molecules 
were gradually placed in electron  density of at least 3o- 
above  the  mean  in  a  difference  Fourier  map,  within  a 
distance of 2.4-3.5 A from a neighbouring O or N atom, 
and  provided  that  good  density  in  a  o-A-weighted 
2F  o -F c  omit  map  was  present.  The  final  refinement 
statistics  are summarized in Table 3. The last refinement 
cycle was repeated with all data including the test set and 
resulted  in  a  structure  with  an  R  factor  of  18.9%. 
Stereochemistry  was  inspected  with  the  programs 
PROCHECK (Laskowski, MacArthur, Moss & Thornton, 
1993) and  WHAT CHECK (Vriend &  Sander,  1993). 
2.6.  Comparison of  phase sets 
Phase differences  between phase  sets were calculated 
with  the  programs  PH_RMS  (V.  Lamzin,  unpublished 
work) and SFTOOLS (BIOMOL software). Map correla- 
tion  coefficients  were  calculated  with  the  program 
MAPMAN  (Kleywegt  &  Jones,  1996)  and  OVERLAP- 
MAP (Collaborative  Computational  Project,  Number 4, 
1994) by comparing F o electron-density maps computed 
with  the  observed  structure-factor  amplitudes  and 
selected phase sets.  The different pseudo protein models 
were  analysed  for  common  atoms  with  the  program 
MCFMAN (BIOMOL software). 
3. Results and discussion 
3.1. MIRAS phasing 
The X-ray structure of Slt35 was elucidated using five 
heavy-atom  derivatives  with  inclusion  of  anomalous 
scattering  differences  (Tables  1  and  2).  Although 
derivatives Hg-I, Hg-II and Hg-III share similar binding 
sites,  all  sets  were  useful  for  the  phasing,  as  the 
occupancies  of the  sites  differed  significantly.  Further- 
more,  Hg-I  and  Hg-II  contributed  in  particular  to  the 
isomorphous phasing power,  while Hg-III was collected 
with synchrotron radiation at a wavelength optimized for 
anomalous  scattering  differences.  Another  reason  to 
include  both  Hg-I  and  Hg-II  in  the  phasing  was  that 
these  derivatives  had  a  poor  completeness  of 43.2  and 
57.1%, respectively,  in the highest resolution shell (2.91- 
2.70 A), but a more reasonable  combined  completeness 
of 72.0%. 
The  heavy-atom binding  sites  were  examined  in  the 
final  Slt35  structure  (Table  4).  In  all  derivatives,  one 
common  heavy-atom  binding  site  was  present  near 
residue  His263  with  additional  binding  contributions 
from  Tyr234,  Tyr259  or  Arg337.  A  second  common 
binding site for the mercury and osmium derivatives  was 
observed close to another histidine residue (His340). The 
side  chain  of this  histidine  is  exposed  to  the  solvent 
explaining  why  the  mercury  and  osmium  compounds 
bind at several slightly different positions to this residue. 
As all heavy-atom soaking experiments have been carried 
out  at  pH  8.0  (only  Pb-I  was  soaked  at  pH  8.5),  the 
unprotonated  histidine  imidazole  ring  appeared  to  be  a 
good nucleophile to displace chloride  from the mercury 
compounds  (Petsko,  1985). Also  His243  provided  a 
mercury  binding  site.  In  total,  three  out  of the  seven 
histidine residues in Slt35  are involved in the binding of 
the  mercury  compounds.  The  remaining  histidine 
residues  are  involved  in  a  hydrogen-bonding  network 
and are not accessible to the heavy-atom compounds. 
3.2.  The initial map and phase improvement by standard 
methods 
An electron-density  map calculated  with the  MIRAS 
phases  to 2.7 A  resolution  did  indicate  elements  of the 
secondary  structure.  However,  several regions  were not 
readily  interpretable.  Solvent  flattening,  histogram 
matching  and phase  extension  (Cowtan &  Main,  1993) 
to 2.5 A resolution decreased the mean phase difference 
with the phases derived from the final refined model from 
54.3  to  45.4 °  (24.0-2.7 A,  Fig.  4).  In  the  2.7-2.5 A 
resolution range, the inclusion of histogram matching in 
the solvent flattening and phase extension procedure had 
a very favourable effect on the extended  phases,  which 
had their mean phase error decreased from 79.5 to 68.1 °. 
The  overall  mean  phase  error  was  50.0 °  (24.0-2.5 A). 
Nevertheless, the resulting 2.5 A map (Fig. 5b), although 
improved,  still  had  regions  that  were  very  difficult  to 
interpret. 
3.3.  Phase improvement and extension with wARP 
To  further  improve the phases  we applied  the  wARP 
procedure.  Initially,  this  was  carried  out  with  data  to 
2.0 A resolution, which resulted in a map that was readily 
interpretable (Fig. 5d). Main chain and side chains could 
be  easily recognised  and,  therefore,  the  building  of the 
S1t35 model  was  very  easy.  Subsequently,  even  better 
results  were  obtained  using  data  extending  to  1.7 A 
resolution  (Fig. 4 and 5e). 
In the  following sections  we  analyse  the  capabilities 
and the limitations of wARP The influence of parameters 
such  as  the  resolution  of the  diffraction  data  and  the 
reciprocal-space refinement method is discussed. The use 
of the Rf~e factor,  as  opposed  to the  standard  R  factor 
combined with wARP weights, to judge the effectiveness 
of wARP is also discussed. 
3.3.1.  Refinement of the pseudo protein  models.  The 
central concept of wARP is that independent  refinement 
of  several  pseudo  protein  models,  consisting  of  free 
atoms only, at sufficiently high resolution will lead to sets VAN ASSELT, PERRAKIS, KALK, LAMZIN AND DIJKSTRA 
Table 5.  Comparison of the various pseudo protein models 
(a) Comparison of the three starting models 
Pseudo protein  No. of atoms 
model  ~r cutoff  placed 
1  1.6  4160 
2  1.3  5946 
3  1.0  8187 
No. of atoms  Common atom 
selected  positions to modelt  Mean phase differences (8.0-1.7 A) with model 
2  3  2  3  S1t35 
2750  2518  2676  26.1  24.6  67.4 
2750  --  2674  --  25.7  67.6 
2750  2674  --  25.7  --  67.1 
67 
(b) Final mean phase differences (°) between SFALL/ARP-refined  pseudo protein models with each other, their averaged phase set and the final S1t35 
model. Data from 8.0 to  1.7 A  resolution was used during the refinement, with 5% of the data set aside for a test set. 
Model  1  2  3  4  5  6  Averaged  Final Slt35 
model 
1  --  55.9  54.9  48.6  57.7  57.0  35.6  53.4 
2  --  55.8  58.1  49.1  58.1  36.6  54.7 
3  --  57.1  57.5  48.4  35.8  55.2 
4  --  58.7  59.1  37.9  56.1 
5  --  58.8  38.3  55.8 
6  --  38.0  56.8 
Averaged  --  44.9 
(c) Final mean phase differences (°) between SFALL/ARP-refined  pseudo protein models with each other, their averaged phase set and the final Slt35 
model.  All data from 8.0 to  1.7/~ resolution was used during the refinement, including the data in the test set. 
Model  1  2  3  4  5  6  Averaged  Final  S1t35 
model 
1  --  53.7  56.1  46.9  57.1  56.5  35.7  53.6 
2  --  53.9  55.7  46.1  55.2  33.9  51.9 
3  --  57.0  56.2  46.7  35.7  54.0 
4  --  57.8  57.4  37.1  54.4 
5  --  57.7  37.1  53.5 
6  --  36.6  54.3 
Averaged  --  43.2 
(d) Final mean phase differences (°) between REFMAC/ARP refined pseudo protein models with each other, their averaged phase set and the final 
Slt35  model. Data from 8.0 to  1.7 A  resolution was used during the refinement, with 5% of the data set aside for a test set. 
Model  1  2  3  4  5  6  Averaged  Final Slt35 
model 
1  --  31.6  34.3  26.9  29.2  31.8  19.3  30.2 
2  --  35.0  31.1  29.6  34.1  21.4  32.8 
3  --  35.0  35.3  32.0  24.0  36.1 
4  --  27.8  31.8  19.0  28.1 
5  --  31.4  19.1  29.0 
6  --  21.3  32.8 
Averaged  --  24.3 
(e) Final mean phase differences (°) between REFMAC/ARP-refined pseudo protein models with each other, their averaged phase set and the final 
Slt35  model. All data from 8.0 to  1.7/k resolution was used during the refinement,  including the data in the test set. 
Model  1  2  3  4  5  6  Averaged  Final Slt35 
model 
t  2450 atoms were placed at common positions (same grid points) in all three starting pseudo protein models. 
1  --  25.5  26.2  23.4  24.7  24.5  15.9  27.3 
2  --  26.9  25.3  23.6  25.5  16.7  27.6 
3  --  26.4  26.4  24.7  17.7  28.7 
4  --  23.6  24.3  15.6  26.1 
5  --  24.5  15.5  25.8 
6  --  15.8  25.9 
Averaged  --  21.7 68  STRUCTURE ELUCIDATION OF Slt35  USING wARP 
of phases,  which  can  be  combined  into  a  new  set  of 
phases  with  lower  noise  and  less  systematic  error  than 
those  from  each  of the  individual  models.  In  the  three 
starting  models  about  90%  of the  atoms  (2 450  out  of 
2 750) occupy the same positions (Table 5a),  leading to 
modest  mean  phase  differences  between  the  models  of 
about  25 ° .  In  contrast,  the  phases  from  each  of  the 
individual models differ by about 67 ° from the final Slt35 
structure (Table 5a). 
At  the  end  of  a  REFMAC/ARP  refinement  to  1.7 A 
resolution, the six pseudo protein models  still had mean 
phase differences of around 25 ° with each other, but only 
about 27 ° with the final refined Slt35 structure (Table 5e). 
Although  at  this  resolution  stand-alone  REFMAC/ARP 
refinement  of  a  single  pseudo  protein  model  is  thus 
sufficient to eliminate random noise to a large extent and 
to  dramatically improve the phases,  vector averaging of 
structure  factors  from  the  six  refined  models  results  in 
phases that are even closer to those from the final Slt35 
model  (mean  phase  difference  of 21.7°).  This  shows 
clearly that vector averaging is a very effective method in 
wARP to further improve phases without the need for any 
prior  map  interpretation  or  model  building.  Fig.  5 
compares  representative  parts  of  the  electron-density 
map at the various stages of the structure determination. 
Our  results  are  in  agreement  with  earlier  observations 
that  averaging  of  structure  factors  from  a  family  of 
refined structures, reduces the effect of local errors (Rice 
&  Brfinger,  1994;  Brfinger, Adams &  Rice,  1997). 
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Fig.  6.  Mean phase  differences as  a  function  of resolution between  a 
pseudo  protein  model  and  the  final  refined  Slt35  structure  at  the 
beginning of the refinement (--), at the end of the refinement (- -  -), 
and after averaging of all six refined pseudo protein models ( .....  ) 
using  REFMAC/ARP  (a)  or  SFALL/ARP  (b)  with  diffraction  data 
between  8.0  and  1.7 A  resolution.  No test set was used  during  the 
refinement. 
3.3.2.  Comparison  of different  refinement  protocols. 
wARP allows the use of different refinement programs. In 
our  analysis  we  compared  REFMAC  (maximum-like- 
lihood  refinement)  and  the  least-squares  refinement 
program SFALL. Both refinement protocols worked well 
in combination  with ARP in our hands when using data 
extending  to  1.7 A  resolution.  However,  Fig.  6  shows 
clearly that REFMAC produces much better phases than 
SFALL. Not only is the overall phase  error lower,  but it 
also increases  less with resolution. 
g-. 
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Fig.  7.  Analysis  of the  effectiveness  of wARP  as  a  function  of the 
number of observations  in  the  work  set divided  by the  number of 
protein atom parameters (x, y, z and B for 2456 atoms). (a) The mean 
phase difference to the phases from the final refined  S1t35  structure 
and  (b)  the  mean  W,~.4  ~  from vector averaging  of pseudo  protein 
models  refined  with REFMAC/ARP  (filled  squares)  or SFALL/ARP 
(open triangles).  (c) AMCC, the map correlation coefficient (MCC) 
to  the  final  map  for REFMAC/ARP  refinement minus  that  for the 
SFALL/ARP  refinement.  A W~.ARp, the  difference  in  mean  W~Ane of 
REFMAC/ARP  and SFALL/ARP refinement, which is fully correlated 
with  AMCC,  while  ARer  ~, the difference in Rf~= of REFMAC/ARP 
and SFALL/ARP  refinement,  shows  completely opposite behaviour. 
5%  of  the  reflections  was  set  aside  for  a  test  set  during  the 
refinement.  See Table 6  for more details. VAN ASSELT, PERRAKIS, KALK, LAMZIN AND DIJKSTRA  69 
Table  6.  Statistics of vector-averaged structure factors from  REFMAC/ARP or SFALL/ARP refinements at various 
resolutions 
Resolution range (A)  8.00-2.50  8.00-2.30  8.00-2.15  8.00-2.00  8.00-1.85  8.00-1.70  8.00-1.70"r 
Observations-to-parameters ratio~  1.30  1.67  2.04  2.54  3.17  3.98  4.18 
(a) REFMAC/ARP refinement 
Mean phase difference (°)§  59.3  52.2  46.4  42.2  33.4  24.3  21.7 
Rwork factor (%)  18.0  18.0  16.1  16.0  16.0  15.0  15.2 
Rf~e~ factor (%)  46.0  42.0  39.0  35.6  31.5  25.2  -- 
Mean W~ARe  0.574  0.613  0.665  0.681  0.710  0.774  0.817 
Map correlation coefficient§ 
Using no W,,,An  e  weights  0.653  0.740  0.802  0.837  0.891  0.942  0.954 
Using WwARp weights  0.685  0.764  0.820  0.852  0.900  0.945  0.956 
(b) SFALL/ARP refinement 
Mean phase difference (°)§  50.4  50.8  49.6  49.0  46.4  44.9  43.2 
Rwo~k factor (%)  13.7  13.1  14.0  15.1  16.1  17.3  17.3 
Rf~ee factor (%)  34.8  31.6  30.4  29.2  29.0  28.3  -- 
Mean W,  AR  P  0.662  0.648  0.637  0.628  0.628  0.608  0.618 
Map correlation coefficient¶ 
Using no  WwARe weights  0.755  0.760  0.772  0.780  0.787  0.814  0.825 
Using W,.Am, weights  0.776  0.782  0.794  0.801  0.816  0.830  0.841 
t All diffraction data were used in the refinement, including the data in the test set.  ++ The observations-to-parameters ratio is here defined as the 
number of reflections in the work set divided by the number of protein atom parameters (x,  y, z and B  times 2456  atoms).  § Mean phase 
differences between vector-averaged phases from the  final Sit35  structure.  ¶Using  the vector-averaged phases,  non-Wwane weighted and 
WwAm,, weighted F o electron-density maps were calculated and compared with a F,, electron-density map calculated with phases of the final 
refined Slt35  structure.  The map correlation coefficient for the F o electron-density map calculated with the  DM-modified phases to 2.50,~ 
resolution was 0.732 and 0.743  if FOM weights were used. The mean phase error for the DM-modified phases was 50.0  °. 
To further analyse the efficacy of wARP, we applied the 
two  refinement  protocols  at  different  resolutions  to  the 
same  starting pseudo  protein models.  As the number of 
observations  in  a  data  set does  not  only depend  on the 
resolution  but also  on the solvent content  of the crystal 
and  the  completeness  of the  data,  we  prefer to  use  the 
observations-to-parameters  ratio. Fig. 7a shows that from 
an  observations-to-parameters  ratio  higher  than  about 
1.8, REFMAC/ARP refinement gives lower phase  errors 
than SFALL/ARP refinement.  From this we  suggest that 
also  for  other  crystals  the  REFMAC/ARP  protocol  is 
preferable  provided  that  the  observations-to-parameters 
ratio  is sufficient.  It is also evident  from the figure that 
the more  reflections  are  included  in  the refinement,  the 
larger the phase improvement is. 
3.3.3. The Rfreefactor.  Initially we thought that the Rfree 
factor  was  a  good  indicator  to  compare  the  different 
phase-improvement  protocols  in  the  wARP  procedure. 
However, Table 6 shows that there is no clear correlation 
between Rfree factor and phase error. REFMAC produces 
lower  phase  errors  and  higher  map  correlation  coeffi- 
cients than SFALL at resolution  limits of 2.15,  2.00  and 
1.85 A, while the Rf~ factor is higher. This indicates that 
a low Rf~ee value does not necessarily mean lower phase 
errors,  and  therefore  the  Rf~e~ factor  is  not  a  useful 
parameter  to  compare  least-squares  and  maximum-like- 
lihood refinement in wARP. 
A more important point to be considered is that the use 
of the  Rer~ factor  decreases  the  number  of reflections 
used  in  the  refinement,  reducing  the  observations-to- 
parameters  ratio.  The  influence  of omitting  5%  of the 
data during the refinement can be directly seen in Table 6. 
Comparison of the last two columns shows that inclusion 
of all data to  1.7 A resolution leads to significantly lower 
phase errors. As the atoms in the pseudo protein models 
are  refined  without  restraints  on  atomic  positions  and 
displacement  parameters,  the inclusion  of all diffraction 
data  means  more  crystallographic  restraints  on  the  free 
atoms  during  the  refinement  and  this  results  in  lower 
phase  errors.  Therefore,  omitting  reflections  in  wARP 
reduces  the efficacy of the procedure  and the use of an 
Rfree factor is not recommended. 
3.3.4.  The  mean  WwARP As  shown  in  the  previous 
paragraph,  the  Rf~ec factor  is  not  the  best  choice  to 
evaluate the progress of the phase improvement. A useful 
alternative indicator seems to be the weight  WwARe. The 
parameter  WwA  ~  is  a weight with a value between  zero 
and one that  is assigned  to  each  structure  factor on the 
basis of the vector averaging of the structure factors from 
the  different  pseudo  protein  models.  If  the  models 
resemble  each  other very closely,  this  means  that  there 
is  a  high  correlation  between  the  calculated  structure 
factors, which results in a mean  WwARe close to 1.0. Large 
deviations between models lead to a lower mean  WwA  ~. 
As can be seen from Fig. 7 and Table 6 the highest mean 
WwARe between  SFALL/ARP  and  REFMAC/ARP  refine- 
ment always corresponds  to the set with the best phases 
in contrast to the behaviour of the Rf~ce factor. From this 
we  conclude  that  the  mean  WwARe is  a  better  indicator 
than  the  Rf~ee factor  to  monitor  the  convergence  of the 
procedure.  Moreover, the mean  WwARp correlates reason- 
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thus it may serve as a figure of merit analogous to that in 
e.g.  multiple isomorphous replacement.  Indeed,  the use 
of the individual WwA~ of each reflection as a weight in 
the electron-density map calculations improves the map 
quality (see Table 6). However, it should be stressed that 
the mean  WwAne is a measure of the self-consistency of 
the different phase sets, rather than a true figure of merit. 
3.3.5. Phase combination in case of low observations- 
to-parameters  ratios.  At  low  resolution  when  the 
observations-to-parameters ratio is not high enough for 
ARP to give phase improvement on its own (Lamzin & 
Wilson,  1993),  wARP  may  help  to  reduce  the  phase 
errors. We could slightly improve the 2.5/~ phases from 
solvent flattening and histogram matching by 2.1 ° (data 
not shown), by combining them with the phases derived 
from the  three  initial unrefined pseudo  protein models 
using the program SIGMAA  (Read,  1986).  Attempts to 
improve the phases by combining them with the vector- 
averaged phase  set from the six pseudo protein models 
refined  at  2.5 A  with  SFALL  or  REFMAC  were  not 
successful,  however.  Probably the refinements  at 2.5 A 
resolution  did not  give  sufficient meaningful  improve- 
ments to the pseudo protein models. 
3.4. Structure of Slt35 
The  2.0A  resolution  electron-density  maps  from 
wARP  were  of outstanding  quality  and  were  used  to 
build the Slt35  structure. The protein main chain could 
be  easily  followed  and  side  chains  could  be  readily 
recognised. Even solvent molecules could be identified in 
the  density maps.  After the model building,  the  X-ray 
structure  of Slt35  was  refined  against  diffraction  data 
between 20.0 and  1.70 A resolution with X-PLOR to an 
Rwork and Rfree of 18.7 and 22.1%, respectively. The final 
crystallographic R factor for all diffraction data is 18.9%. 
The current X-ray structure contains residues 42-97 and 
109-361, five alternate side-chain conformations and 312 
solvent  molecules.  The  first  three  N-terminal  residues 
(Met39, Val40 and Leu41) and residues 98-108 are not 
visible in the electron-density maps. Continuous electron 
density is observed for the rest of main chain, except for 
two small breaks in the main chain at residues 46 and 48. 
According  to  PROCHECK  (Laskowski  et  al.,  1993), 
91.2%  of the qg/Tz angles fall inside the most favoured 
regions  of the  Ramachandran  plot  and  the  rest  in  the 
additionally allowed regions (Fig. 8). 
The X-ray structure of Slt35 consists of three domains 
named  the  alpha,  beta  and  core  domains.  The  alpha 
domain contains mainly a-helices as secondary-structure 
elements and it is found at the bottom of the model in the 
orientation as given in Fig. 9. A  r-sheet domain of five 
antiparallel r-strands flanked by one a-helix is observed 
on  top  of the  protein  and  is  called  the  beta  domain. 
Sandwiched between the alpha and beta domains is the 
core domain containing a-helices and a large groove. The 
latter domain bears some resemblance to the fold of the 
catalytic domain of Slt70  (Thunnissen et al.,  1994).  A 
superposition  of these  two  domains  revealed  that  the 
catalytic Glu478 of Slt70 coincides with Glu162 of Slt35 
(not shown). A more detailed analysis of the architecture 
of Slt35  is in preparation (van Asselt,  Dijkstra,  Kalk, 
Keck & Dijkstra,  1998). 
Slt70  is  a  doughnut-shaped  exo-muramidase,  which 
cleaves  1,6-anhydromuropeptides from the  1,6-anhydro- 
muramate end of glycan strands processing towards the 
N-acetylglucosamine end. It has been proposed that the 
doughnut  domain  of Slt70  is  responsible  for this  exo- 
activity (Thunnissen et al.,  1994).  In the case of Slt35, 
there is no such doughnut domain. Nevertheless, enzyme 
activity studies with radioactive double-labelled peptido- 
glycan  material  have  shown  that  Slt35  is  an  exo- 
muramidase as well (Romeis, Vollmer &  H61tje,  1993). 
It might be possible that residues 98-108, unfortunately 
not seen in the electron density, form a mobile loop from 
the alpha to the core domain that might fulfil a  similar 
role to the Slt70 doughnut domain and prevent the endo- 
activity  of  the  enzyme.  As  the  active  site  of  Slt70 
superimposes on the core domain of Slt35, it seems likely 
that Slt35 starts degradation of peptidoglycan at the 1,6- 
anhydromuramate end  of the glycan strand as well.  To 
more  clearly  understand  how  Slt35  interacts  with  its 
substrate, further crystallographic studies are under way. 
4. Conclusions 
The first application of wARP in the structure determina- 
tion of a protein at high resolution starting from medium- 
resolution MIRAS phases is described. Phases could be 
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Fig.  8.  Ramachandran plot for the final  Slt35  structure,  as calculated 
with the program PROCHECK (Laskowski et al.,  1993). 91.2% of 
the  residues  are  in  the  most  favoured  regions  and  8.8%  in  the 
additionally allowed regions.  Glycine residues  are  shown  as  filled 
triangles and the other residues as filled squares. VAN  ASSELT,  PERRAKIS,  KALK,  LAMZIN  AND  DIJKSTRA  71 
the requirement of an atomic model. Our first approach to 
apply  wARP  using  data  to  2.0 A  resolution  resulted 
already in electron density of such excellent quality that 
the complete protein model could be built in only a few 
days. Later studies showed that even better results could 
be  obtained  by  using  all  diffraction  data  to  1.7A 
resolution. This latter approach resulted in a mean phase 
difference of only 21.7 ° compared with the phases from 
the final Slt35 structure. The structure of Slt35 consists of 
three domains and it has been refined to 1.7 A resolution 
18.9%. The core domain bears some resemblance to the 
catalytic  domain  of  Slt70,  while  the  alpha  and  beta 
domains are completely different. 
To  monitor  the  progress  and  the  reliability  of  the 
different  refinement  protocols  in  wARP,  we  initially 
thought that the Rfree  factor might be  a  good indicator. 
However,  it  appeared  that  setting  aside  5%  of  the 
diffraction  data  for  an  Rfree test  set,  negatively affects 
the  phase  improvement.  Instead,  the  mean  Ww.4n  e  is  a 
better parameter to judge  different phase  improvement 
with  X-PLOR  to  a  final  crystallographic  R  factor  of  protocols. Hence, it is recommended not to use an Rf~ee 
(a) 
C  C 
(b) 
Fig.  9.  (a)  Stereoview of the  Slt35 
structure with the alpha domain at 
the bottom, the beta domain at the 
top of the molecule and the core 
domain  in  the  centre.  (b)  Stereo 
figure of Slt35  viewed along  the 
peptidoglycan binding  cleft.  The 
proposed catalytic acid Glu162  is 
indicated in  ball  and stick repre- 
sentation in the core domain. The 
picture was produced with MOL- 
SCRIPT (Kraulis, 1991). 72  STRUCTURE  ELUCIDATION OF Slt35 USING  wARP 
test set, but to  include all diffraction data to  the highest 
resolution  available in the  wARP  procedure.  The  better 
observations-to-parameters  ratio  will  improve  the  con- 
vergence rate of the refinement and the chance to succeed 
with  wARP.  In  the  case  of Slt35,  maximum-likelihood 
refinement in wARP gave much better phases than least- 
squares  refinement,  provided  that  the  observations-to- 
parameters ratio was approximately 1.8 or higher. 
In  our  hands,  wARP  appeared  to  be a  very powerful 
tool  for  improving experimental  phases  and  extending 
them  to  higher  resolution.  The  electron-density  maps 
calculated  with  the  final  wARP  phases  facilitated  the 
interpretation of the map enormously and accelerated the 
building of the Slt35  X-ray structure.t 
The result of this study helped to completely automate 
the entire wARP procedure,  starting from the placement 
of O  atoms  in  a  fine-grid electron-density  map  to  the 
calculation of the final wARP electron-density map. The 
user  has  to  provide  the  best  available electron-density 
map,  covering  one  asymmetric  unit,  together  with 
diffraction data and an arbitrarily placed piece of atomic 
model  (e.g.  an  a-helix)  inside  the  core  of the  protein 
electron  density.  Additional parameters  that  have to  be 
provided  by the  user  are  the  space  group,  cell  dimen- 
sions,  resolution  limits,  grid  spacing  for  calculating 
electron-density  maps,  asymmetric  unit  limits,  the  B 
factor  derived  from  a  Wilson  plot  and  the  estimated 
number  of  protein  atoms.  A  choice  should  be  made 
between  least-squares  and  maximum-likelihood refine- 
ment.  Six pseudo  protein  models are generated,  refined 
and  finally  vector-averaged  in  one  go  and  the  high- 
resolution  output  map  is  calculated.  All  log  files  are 
summarized to  check the progress  during refinement of 
the different models. The refinement of the models can 
be parallelized by automatically distributing the calcula- 
tions  to  up  to  six  different  computers,  which  share 
common disk storage  space,  reducing the  total  calcula- 
tion time.  Another requirement is that  the  user has the 
CCP4  program  suite,  ARP  and  MOLEMAN.  All  other 
programs  and  C-shell  scripts  are  distributed  together 
within the wARP package, which is available through the 
WWW at http://den.nki.nl/---perrakis/arp.html. 
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